Natera (NTRA) PT Raised to $80 at Piper Sandler
Tweet
Share
E-mailGet Alerts NTRA Hot Sheet
Price: $326.26 -3.67%
Rating Summary:
25 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
25 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Piper Sandler analyst Dave Westenberg raised the price target on Natera (NASDAQ: NTRA) to $80.00 (from $70.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Natera partners with Angiex to monitor cancer drug trial with ctDNA test
- Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
- Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
